Skip to content
★ Sign in to follow
AP

ASKA Pharmaceutical Holdings Co., Ltd. Stock: price and insider trades · Japan

あすか製薬ホールディングス株式会社

JP·Mcap JP¥57.6BBanks

No insider purchase over the last 90 days. The latest, by Unknown, was filed 09 Jun 2022.

ASKA Pharmaceutical Holdings Co., Ltd.: what insiders have been doing

ASKA Pharmaceutical Holdings Co., Ltd., founded in 2005, is a Banks company based in Tokyo, Japan. Its directors and officers file their transactions with EDINET (Japan FSA). In the past year (26 October 2025 to 26 October 2026), 1 filing came from 1 insider.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Over the last twelve months, not one insider purchase of ASKA Pharmaceutical Holdings Co., Ltd. stock was filed.

Across the 3,205 companies tracked on its exchange, the median is 3 filings; at 1 filing, this issuer sits below that mark. Over the whole record (from 2022), the tally stands at 16 purchases and no sales.

This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.

Key facts

Headquarters: Tokyo, Japan · Founded: 2005

Source: Wikidata (CC0).

Insider Decl.
32
Thresholds
n/a
Buy Volume
€637,105
16 ops. · all time
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 4,463 of 26,911 companies
69.1
score / 100
Value
76
Quality
62
FCF yld6.0%
Earn yld9.4%
EV/EBITDA6.8x
ROE6.6%
Gross mgn48%
Net mgn7.6%
Debt/EBITDA1.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥2,023
Analyst consensus
1 analysts
·
JP¥2,400Target JP¥2,400(+19%)JP¥2,400
Income statement
RevenueJP¥71.1B
Gross profitJP¥34.1B48% margin
EBITDAJP¥10.1B14% margin
Net incomeJP¥5.4B6.8% margin
Valuation
PER (trailing)12.6x
P/Book0.8x
Beta0.44
Balance sheet & cash
Market capJP¥57.6B
Total debtJP¥11.4B
Free Cash FlowJP¥3.4B
Debt / Equity15%
Profitability & ownership
ROE6.6%
ROA3.0%
% insiders24.1%
% institutions33.5%
Last declaration on 8 April 2026
Declarations32 total
  • ●
    Related company / holdingExecutives
    6EDINET
    9.8% of flowShareXTKSEDINET:S100XJME
  • ●
    Related company / holdingExecutives
    6EDINET
    11.0% of flowShareXTKSEDINET:S100VQ3T
  • ●
    Related company / holdingExecutives
    6EDINET
    11.0% of flowShareXTKSEDINET:S100VGLW
  • ●
    Related company / holdingExecutives
    6EDINET
    11.2% of flowShareXTKSEDINET:S100VBW1
  • ●
    Related company / holdingExecutives
    6EDINET
    8.9% of flowShareXTKSEDINET:S100UVXF
  • ●
    Related company / holdingExecutives
    6EDINET
    7.9% of flowShareXTKSEDINET:S100UUW2
  • ●
    Related company / holdingExecutives
    6EDINET
    7.5% of flowShareXTKSEDINET:S100UIPI
  • ●
    Related company / holdingExecutives
    6EDINET
    7.1% of flowShareXTKSEDINET:S100U6FQ
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100U3G5
  • ●
    Related company / holdingExecutives
    6EDINET
    6.2% of flowShareXTKSEDINET:S100U2BU
  • ●
    Related company / holdingExecutives
    6EDINET
    6.3% of flowShareXTKSEDINET:S100T923
  • ●
    Related company / holdingExecutives
    6EDINET
    5.2% of flowShareXTKSEDINET:S100T7K4
  • ●
    Related company / holdingExecutives
    5EDINET
    4.5% of flowShareXTKSEDINET:S100SKYQ
  • ●
    Related company / holdingExecutives
    5EDINET
    3.3% of flowShareXTKSEDINET:S100SCKP
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100PSTH
  • ●
    Unknown
    Large shareholderExecutives
    11EDINET
    61.6% of flowShareXTKSEDINET:S100O7UL
  • ▲
    Unknown
    Large shareholderExecutives
    €154kest.0EDINET
    10,000 sharesShareXTKSEDINET:S100O7UL:T1
    Canonical exit: 11 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €67kest.0EDINET
    4,500 sharesShareXTKSEDINET:S100O7UL:T2
    Canonical exit: 14 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €37kest.0EDINET
    2,500 sharesShareXTKSEDINET:S100O7UL:T3
    Canonical exit: 15 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €61kest.0EDINET
    4,100 sharesShareXTKSEDINET:S100O7UL:T4
    Canonical exit: 16 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €88kest.0EDINET
    6,000 sharesShareXTKSEDINET:S100O7UL:T5
    Canonical exit: 17 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €7,324est.0EDINET
    500 sharesShareXTKSEDINET:S100O7UL:T6
    Canonical exit: 18 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €15kest.0EDINET
    1,000 sharesShareXTKSEDINET:S100O7UL:T7
    Canonical exit: 21 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €26kest.0EDINET
    1,800 sharesShareXTKSEDINET:S100O7UL:T8
    Canonical exit: 22 Aug 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    €44kest.0EDINET
    3,000 sharesShareXTKSEDINET:S100O7UL:T10
    Canonical exit: 25 Aug 2022 (T+90)

25 of 32 declarations

About ASKA Pharmaceutical Holdings Co., Ltd.

Asuka Pharmaceutical Holdings Co., Ltd. is a Japanese company specializing in the pharmaceutical sector, providing health-related products and services. It is listed on the Tokyo Stock Exchange under the symbol XTKS.